Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Financial and others

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jul 15, 2021 8:15am

129 Views

Post# 33548091

RE:RE:RE:RE:RE:Financial and others

Contrary to my expectations only 197000 warrants were exercised,,,,,

palinc2000 wrote: I meant just recently like a few days ago or a moth or more

scarlet1967 wrote: It seems like it has started:
"An external U.S.-based biopharma advisory firm has been retained to assist in identifying a potential partner."

palinc2000 wrote: Not clear to me if the search for a partner has started or is in the process of being initiated...
If not started yet why did they wait?